Cargando…

Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus

BACKGROUND: Blood Oxygen Level Dependent (BOLD) magnetic resonance (MR) is a novel imaging tool that detects changes in tissue oxygenation. Increases in renal oxygenation in response to a standard 20 mg intravenous furosemide stimulus have been evaluated to assess kidney viability in patients with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Michael E, Rocco, Michael V, Morgan, Timothy M, Hamilton, Craig A, Edwards, Matthew S, Jordan, Jennifer H, Hurie, Justin B, Hundley, W Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914363/
https://www.ncbi.nlm.nih.gov/pubmed/24490671
http://dx.doi.org/10.1186/1532-429X-16-17
_version_ 1782302393487065088
author Hall, Michael E
Rocco, Michael V
Morgan, Timothy M
Hamilton, Craig A
Edwards, Matthew S
Jordan, Jennifer H
Hurie, Justin B
Hundley, W Gregory
author_facet Hall, Michael E
Rocco, Michael V
Morgan, Timothy M
Hamilton, Craig A
Edwards, Matthew S
Jordan, Jennifer H
Hurie, Justin B
Hundley, W Gregory
author_sort Hall, Michael E
collection PubMed
description BACKGROUND: Blood Oxygen Level Dependent (BOLD) magnetic resonance (MR) is a novel imaging tool that detects changes in tissue oxygenation. Increases in renal oxygenation in response to a standard 20 mg intravenous furosemide stimulus have been evaluated to assess kidney viability in patients with renal artery stenosis (RAS). The effect of prior exposure to furosemide on the ability of BOLD MR techniques to evaluate renal function is unknown. This study tested the hypothesis that chronic loop diuretic therapy is associated with attenuated responses in renal tissue oxygenation as measured by BOLD MR with an acute 20 mg intravenous furosemide stimulus in participants undergoing evaluation for RAS. METHODS: Thirty-eight participants referred for evaluation of RAS were recruited for this study. We examined renal cortical and medullary BOLD signal (T2*) intensities before and after a 20 mg intravenous furosemide stimulus. Additionally, we measured changes in renal artery blood flow using phase contrast techniques. RESULTS: After controlling for covariates age, race, gender, diabetes, glomerular filtration rate, body mass index, and stenosis severity, daily oral furosemide dose was an independent, negative predictor of renal medullary T2* response (p = 0.01) to a standard 20 mg intravenous furosemide stimulus. Stenosis severity and ethnicity were also significant independent predictors of changes in T2* signal intensity in response to an acute furosemide challenge. Changes in renal blood flow in response to acute furosemide administration were correlated with changes in T2* in the renal cortex (r = 0.29, p = 0.03) but not the medulla suggesting changes in renal medullary oxygenation were not due to reduced renal medullary blood flow. CONCLUSIONS: Chronic furosemide therapy attenuates BOLD MR responses to an acute furosemide stimulus in patients with RAS being evaluated for renal artery revascularization procedures. Thus, patients who are chronically administered loop diuretics may need a different dosing strategy to accurately detect changes in renal oxygenation with BOLD MR in response to a furosemide stimulus.
format Online
Article
Text
id pubmed-3914363
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39143632014-02-06 Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus Hall, Michael E Rocco, Michael V Morgan, Timothy M Hamilton, Craig A Edwards, Matthew S Jordan, Jennifer H Hurie, Justin B Hundley, W Gregory J Cardiovasc Magn Reson Research BACKGROUND: Blood Oxygen Level Dependent (BOLD) magnetic resonance (MR) is a novel imaging tool that detects changes in tissue oxygenation. Increases in renal oxygenation in response to a standard 20 mg intravenous furosemide stimulus have been evaluated to assess kidney viability in patients with renal artery stenosis (RAS). The effect of prior exposure to furosemide on the ability of BOLD MR techniques to evaluate renal function is unknown. This study tested the hypothesis that chronic loop diuretic therapy is associated with attenuated responses in renal tissue oxygenation as measured by BOLD MR with an acute 20 mg intravenous furosemide stimulus in participants undergoing evaluation for RAS. METHODS: Thirty-eight participants referred for evaluation of RAS were recruited for this study. We examined renal cortical and medullary BOLD signal (T2*) intensities before and after a 20 mg intravenous furosemide stimulus. Additionally, we measured changes in renal artery blood flow using phase contrast techniques. RESULTS: After controlling for covariates age, race, gender, diabetes, glomerular filtration rate, body mass index, and stenosis severity, daily oral furosemide dose was an independent, negative predictor of renal medullary T2* response (p = 0.01) to a standard 20 mg intravenous furosemide stimulus. Stenosis severity and ethnicity were also significant independent predictors of changes in T2* signal intensity in response to an acute furosemide challenge. Changes in renal blood flow in response to acute furosemide administration were correlated with changes in T2* in the renal cortex (r = 0.29, p = 0.03) but not the medulla suggesting changes in renal medullary oxygenation were not due to reduced renal medullary blood flow. CONCLUSIONS: Chronic furosemide therapy attenuates BOLD MR responses to an acute furosemide stimulus in patients with RAS being evaluated for renal artery revascularization procedures. Thus, patients who are chronically administered loop diuretics may need a different dosing strategy to accurately detect changes in renal oxygenation with BOLD MR in response to a furosemide stimulus. BioMed Central 2014-02-03 /pmc/articles/PMC3914363/ /pubmed/24490671 http://dx.doi.org/10.1186/1532-429X-16-17 Text en Copyright © 2014 Hall et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hall, Michael E
Rocco, Michael V
Morgan, Timothy M
Hamilton, Craig A
Edwards, Matthew S
Jordan, Jennifer H
Hurie, Justin B
Hundley, W Gregory
Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title_full Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title_fullStr Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title_full_unstemmed Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title_short Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus
title_sort chronic diuretic therapy attenuates renal bold magnetic resonance response to an acute furosemide stimulus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914363/
https://www.ncbi.nlm.nih.gov/pubmed/24490671
http://dx.doi.org/10.1186/1532-429X-16-17
work_keys_str_mv AT hallmichaele chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT roccomichaelv chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT morgantimothym chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT hamiltoncraiga chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT edwardsmatthews chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT jordanjenniferh chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT huriejustinb chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus
AT hundleywgregory chronicdiuretictherapyattenuatesrenalboldmagneticresonanceresponsetoanacutefurosemidestimulus